Vericel Corporation (VCEL) News
Filter VCEL News Items
VCEL News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
VCEL News Highlights
- VCEL's 30 day story count now stands at 3.
- Over the past 8 days, the trend for VCEL's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
Latest VCEL News From Around the Web
Below are the latest news stories about VERICEL CORP that investors may wish to consider to help them evaluate VCEL as an investment opportunity.
The five-year returns have been solid for Vericel (NASDAQ:VCEL) shareholders despite underlying losses increasingThe most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company... |
Insider Sell: Director Paul Wotton Offloads 5,000 Shares of Vericel Corp (VCEL)Vericel Corp (NASDAQ:VCEL), a leader in the field of regenerative medicine, has recently witnessed a significant insider sell that has caught the attention of investors and market analysts. |
Insider Sell: President and CEO Dominick Colangelo Sells 24,397 Shares of Vericel Corp (VCEL)Vericel Corp (NASDAQ:VCEL), a leader in the field of regenerative medicine, has recently witnessed a significant insider sell by its President and CEO, Dominick Colangelo. |
Insider Sell: COO Michael Halpin Sells 17,447 Shares of Vericel Corp (VCEL)Vericel Corp (NASDAQ:VCEL), a leader in the field of regenerative medicine, has recently witnessed a significant insider transaction. |
Insider Sell: Chief Medical Officer Jonathan Hopper Sells 5,000 Shares of Vericel Corp (VCEL)Vericel Corp (NASDAQ:VCEL), a leader in the field of regenerative medicine, has recently seen a significant insider transaction. |
3 Biotech Stocks That Could Boom or Bust by 2025Biotech stocks are popular with investors because they sometimes provide tremendous rewards. |
3 Strong Buy Stocks Set to Take Off in the Coming MonthsThese 3 strong buy stocks have industry experts' positive outlook and seal of approval. |
Vericel Corporation (NASDAQ:VCEL) Q3 2023 Earnings Call TranscriptVericel Corporation (NASDAQ:VCEL) Q3 2023 Earnings Call Transcript November 8, 2023 Vericel Corporation beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.13. Operator: Ladies and gentlemen, thank you for standing by. Welcome to Vericel’s Third Quarter 2023 conference call. At this time, all participants are in a listen-only mode. I would also like remind […] |
Vericel Corp (VCEL) Reports Strong Q3 2023 Results and Raises Full-Year GuidanceRobust Revenue Growth and Positive Adjusted EBITDA Highlighted |
Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial GuidanceRecord Third Quarter Revenue of $45.6 Million, Representing 18% Growth versus Prior Year MACI Revenue Growth of 21% to $37.6 Million Full-Year 2023 Revenue Guidance Raised to $192.5-197.5 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the third quarter ended Se |